Indaco Bio
Galleria San Babila 4/B, Milan, 20122, Italy
Overview
Indaco Venture Partners SGR is the Italian venture capital asset management company, with a strong specialization in companies that innovate in electronics and robotics, medtech, digital, and new materials. The company focused on growth-stage companies whose competitive advantage stems from cutting-edge proprietary technologies and innovations. In terms of teams and technologies, the focus is on Italian enterprises, although investments are made throughout Europe, the USA, Canada, and Israel. Indaco Venture Partners was founded in 2018 and is headquartered in Milan, Lombardia, Italy.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Asset Management
- Electronics
- Financial Services
- Robotics
- Venture Capital
Investment portfolio
- Alia Therapeutics
Participated · Seed · Apr 2023
Alia Therapeutics is a Trento-based spin-off focused on developing innovative treatments for rare genetic diseases using next-generation CRISPR gene-editing technologies. The company was founded in October 2018 by virologist Anna Cereseto and researchers from the University of Trento’s CIBIO department, and was accelerated at BiovelocITA. Alia aims to advance safer, more effective gene-editing strategies to treat currently incurable genetic conditions and to expand its intellectual property portfolio. The firm recently closed a new financing to consolidate its CRISPR platform and support company expansion. Its scientific work has received external recognition, with Cereseto’s research named by Nature among seven technologies to watch in 2023. The company will use the proceeds to advance its development program and strengthen its patent position.
Team
No current team members are available.